You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DILTZAC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Diltzac patents expire, and what generic alternatives are available?

Diltzac is a drug marketed by Apotex and is included in one NDA.

The generic ingredient in DILTZAC is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Diltzac

A generic version of DILTZAC was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DILTZAC?
  • What are the global sales for DILTZAC?
  • What is Average Wholesale Price for DILTZAC?
Summary for DILTZAC
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 58
DailyMed Link:DILTZAC at DailyMed
Drug patent expirations by year for DILTZAC

US Patents and Regulatory Information for DILTZAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-001 Feb 1, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-004 Feb 1, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-002 Feb 1, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-003 Feb 1, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-005 Feb 1, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.